Cite

HARVARD Citation

    Bennett, C. et al. (2021). The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. Oncologist. pp. e1418-e1426. [Online]. 
  
Back to record